Solve Therapeutics, Inc. · CIK 1905252
Solve Therapeutics, Inc.
These Form D notices describe private placements reported to the SEC. Read Form D/A amendments alongside the original disclosures.
Filings
1
Original notices
1
Amendments
0
Activity
Nov 25, 2025
through Nov 25, 2025
through Nov 25, 2025
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Choose filings to compare · Research this issuer step by step
Latest available filing snapshot: how to read these fields
- Reported offering amount
- $120,535,618
- Reported exemptions
- Rule 506(b)
- Reported amount sold
- $48,214,232
This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.
Form D filings (1)
-
0001231919-25-000548D · Nov 25, 2025 · BiotechnologyOffering: $120,535,618Sold: $48,214,232